^2Z&~ l72(p Determination of Possible Interference of Perfluorooctane Sulfonic Acid Potassium Salt with Rat Cholesterol Date: 8/17/99 Study: 6329 263 Serum Vehicle Blank Blank 0 ug/mL 0 ug/mL 1.08 mg 3.23 mg 6.46 mg /mL_______/mL_____ /mL mg/dL #1 mg/dL #2 mg/dL #3 68 66 66 65 67 66 66 65 65 65 65 65 66 66 65 mean s.d. 66.33333 65.66667 65.66667 65.33333 65.66667 1.527525 0.57735 0.57735 0.57735 1.154701 Method Principle (Trinder reaction) Cholesterol esters present in serum or plasma are hydrolyzed qualitatively in to free cholesterol and fatty acids by microbial cholesterol esterase.
refid# np0x0dgZkXq9jEv8BmjJbQ5rm1 page
3M Specialty M ateriali 3M Center St.
refid# k6EyBVg6DbrO8GezrrQkQz0EO1 page
Interim Report #2 Epidemiology, 220-3W-05 Medical Department 3M Company St.
refid# 341gpZgQYgj67v7xJwJV5o4E22 pages
3 FLUOROCHEMICAL SUBMISSION 2005 Click a Month back to year menu TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE February April June August September October
refid# ZgYxLaorw4QBVY2KnZn5DaEJ1 page
Larry R.
refid# 06kqXOb1m2w6qqK36edXwvBvd2 pages
WATER SOLUBILITY (BY ANALYSIS OF TOC) TEST SUBSTANCE Identity: Perfluorooctanesulfonyl fluoride; may also be referred to as POSF, or FX-8. (1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, CAS #30735-7).
refid# OwBZ4Laok5doyXJYEZ4E2Zy16 pages
ACTIVATED SLUDGE RESPIRATION INHIBITION TEST SUBSTANCE Identity: Perfluorooctanesulfonylamido(ethyl)acetate; may also be referred to as PFOSAA, FC-128 or as the major component of FC-127, FC-129, FC-109, or FC-109-X.
refid# nNbXkq1VZkN42JmxLdzQM8k7a4 pages
O R iU crO sn MICROBIOS MICROTOX TOXICITY TEST TEST SUBSTANCE______________ Identity: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA ammonium salt, Ammonium perfluorooctanoate, PFO, FC-116, FC-126, FC-169, FC-143 or as the major component of FC-118.
refid# Rj55pZjVLMy45y0eoLZvXLQQ78 pages
CAS Number 754-91-6 3M Company M 6_T77 Voluntary Use and Exposure Information Profile Perfluorooctane sulfonamide I.
refid# 4aGjnkkoRn8KbJr7dr8263a5114 pages
3M General Offices 3M Center St.
refid# dQOmRyyoM7JvzjJV7xBj7Xgqe11 pages
AU MO?
refid# YwK29g2798QDmoG5QV2KD3NK1 page
AJP003593 AR226-1988 BEST COPY AVAILABLE $9 "K. y x. > ~Q4 4- *k a V ^a l"ur I- o -a 4- 4" s dj i i: ?
refid# aDBKG3ODrR3BYyb32mRBewB6b3 pages
AR226-2086 w m m mRobert F Ptnchot 09/20/99 08:27 AM To: Anthony J Playtis/CUDuPont@DuPont, Robin C Leonard/AE/DuPont@DuPont, Roger J 2ipfel/AE/DuPont@DuPont cc: Subject: C-8 testing at Spruance .
refid# GKkmDGrZE6D3XyppQ4dO9Objx1 page
AR226-2225 Robert F Pinchot 12/07/2001 02:47 PM To: Roger J Zipfel/AE/DuPont@DuPont cc: Debbie J Mulrooney/AE/DuPont@DuPont, Chris E Shoop/AE/DuPont@DuPont Subject: Re: Consent Order - Stack Parameters and Emissions Q ' Roger, Do these data make sense to you?
refid# ZJaOEpJ4wJjmq5xNQg9p8jLJO1 page
iK iid / <uJ4f~ZH, I Based on RAGS (Superfund) guidance, Exhibit 6-11 Intake (mg/kg-day) = CW x IR x EF x ED ^ BWxAT !
refid# RpeN6nD7rG73GN9xOn71RDOn710 pages